Establishment of optimal tissue regenerating procedures using monocyte-derived multipotential cells for tissue regeneration
使用单核细胞衍生的多能细胞进行组织再生,建立最佳的组织再生程序
基本信息
- 批准号:17390284
- 负责人:
- 金额:$ 9.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We recently discovered a primitive human cell population called monocyte-derived multipotential cells (MOMC), which has a fibroblast-like morphology and a unique phenotype positive for CD14, CD45, CD34, and type I collagen. MOMC contain progenitors with capacity to differentiate into a variety of non-phagocytes, including bone, cartilage, fat, skeletal and cardiac muscle, neuron, and endothelium. This study was aimed to assess efficacy of MOMC transplantation in tissue regeneration and to establish optimal culture conditions that generate MOMC for tissue regeneration therapy.1)Evaluation of efficacy of MOMC transplantation in animal modelsEfficacy of transplantation of syngeneic MOMC was assessed using 2 different rat models, including cerebral infarction and skin flap procedure. Rats were subjected to 1 hour of left middle cerebral artery occlusion and received intra-cranial transplantation of MOMCs at day 7. Neurological function assessed by Corner test was improved in rats transplan … More ted of MOMC, but not in control rats transplanted of macrophages or medium alone. In immunohistochemical analysis, the number of newly formed blood vessels was significantly increased in MOMC-transplanted rats, compared with controls rats. Transplanted MOMC were confirmed to be incorporated in blood vessel wall and differentiate into endothelial cells. A principally concordant finding regarding functional improvement and in vivo differentiation of MOMC to endothelial cells was obtained from rat skin flap model.2)Establishment of optimal culture conditions that generate human MOMCWe previously found that MOMC can be enriched in culture of human peripheral blood mononuclear cells on fibronectin-coated plastic plates in the presence of soluble factor(s) derived from activated platelets. Potential platelet-derived factors with such capacity were screened by culturing circulating monocytes in the presence or absence of candidate molecules with molecular weight < 30,000, which were released upon platelet activation. As a result, SDF-1 was identified as a factor that promotes MOMC generation. Based on this, we have successfully developed an ex vivo procedure that generates a large number of human MOMC by culturing circulating monocytes on recombinant fibronectin with exogenous SDF-1.These findings together indicate that MOMC transplantation is a promising strategy that regenerates the damaged tissue. Less
我们最近发现了一种原始的人类细胞群,称为单核细胞衍生多潜能细胞(MOMC),它具有成纤维细胞样的形态,CD14、CD45、CD34和I型胶原呈独特的阳性表型。MOMC含有能够分化为多种非吞噬细胞的前体细胞,包括骨、软骨、脂肪、骨骼和心肌、神经元和内皮细胞。本研究的目的是评价MOMC移植在组织再生中的作用,并建立适合组织再生治疗的MOMC的最佳培养条件。1)动物模型中MOMC移植的效果评价采用两种不同的大鼠模型,包括脑梗塞和皮瓣移植。大鼠左侧大脑中动脉闭塞1h后,于第7天行大鼠大脑中动脉微血管内移植。…移植组大鼠神经功能改善巨噬细胞移植组和单纯培养液移植组大鼠的MOMC数明显增加,而对照组大鼠无明显变化。免疫组织化学分析显示,与对照组相比,移植MOMC的大鼠新生血管数量显著增加。移植的MOMC被证实整合到血管壁中,并分化为内皮细胞。从大鼠皮瓣模型中获得了关于MOMC功能改善和体内向内皮细胞分化的基本一致的发现。2)建立了生成人MOMC的最佳培养条件。我们先前发现,在激活的血小板来源的可溶性因子(S)的存在下,在纤维连接蛋白包裹的塑料平板上,MOMC可以在人外周血单个核细胞的培养中浓缩。通过在存在或不存在分子量为30,000的候选分子的情况下培养循环单核细胞来筛选具有这种能力的潜在的血小板衍生因子,这些分子在血小板激活时被释放。因此,SDF-1被确定为促进MOMC生成的一个因素。在此基础上,我们成功地开发了一种体外方法,通过在含有外源性SDF-1的重组纤维连接蛋白上培养循环单核细胞来产生大量的人MOMC。这些发现共同表明,MOMC移植是一种有前景的再生受损组织的策略。较少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neurogenic potential of progenitors derived from human circulating CD14+ monocytes
- DOI:10.1111/j.1440-1711.2006.01424.x
- 发表时间:2006-04-01
- 期刊:
- 影响因子:4
- 作者:Kodama, H;Inoue, T;Kuwana, M
- 通讯作者:Kuwana, M
Human circulating monocytes as multipotential progenitors
- DOI:10.2302/kjm.56.41
- 发表时间:2007-06-01
- 期刊:
- 影响因子:2
- 作者:Seta, Noriyuki;Kuwana, Masataka
- 通讯作者:Kuwana, Masataka
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUWAMA Masataka其他文献
KUWAMA Masataka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Supramolecular mineralizing materials for dental tissue regeneration
用于牙组织再生的超分子矿化材料
- 批准号:
2534896 - 财政年份:2025
- 资助金额:
$ 9.86万 - 项目类别:
Studentship
An atypical microtubule generation mechanism for neurons drives dendrite and axon development and regeneration
神经元的非典型微管生成机制驱动树突和轴突的发育和再生
- 批准号:
23K21316 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ICF Biologically derived wraps for nerve and tendon regeneration
ICF 生物衍生包裹物,用于神经和肌腱再生
- 批准号:
MR/Z503733/1 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Research Grant
Catalyst aided regeneration of nonaqueous absorbent for low temperature CO2 capture
用于低温二氧化碳捕获的非水吸收剂的催化剂辅助再生
- 批准号:
EP/Y026527/1 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Fellowship
Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
- 批准号:
EP/X027198/2 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Fellowship
BoCP-Implementation: Cascading Impacts of Landscape Structure on Forest Regeneration
BoCP-实施:景观结构对森林再生的级联影响
- 批准号:
2325844 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Standard Grant
Macrophage-polarizing ALMA hydrogels for thyroid regeneration following radiation injury
巨噬细胞极化 ALMA 水凝胶用于放射损伤后甲状腺再生
- 批准号:
MR/Y033817/1 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Research Grant
Project SMILER: A clinical study over the efficacy of the the world's first topical varnish for Stronger MIcro-Layer Enamel Regeneration
SMILER 项目:世界上第一个局部清漆对于增强微层牙釉质再生功效的临床研究
- 批准号:
10072636 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Collaborative R&D
Cellular senescence and regeneration in the epithelia: novel mechanisms and therapeutic approaches
上皮细胞衰老和再生:新机制和治疗方法
- 批准号:
MR/X033155/1 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Fellowship
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




